Consumer diagnostics will be one of several discussions at the INVEST Digital Health conference focused on power shifting to ...

When Slate Medicines launched early this year backed by a mega-round of financing, the company claimed best-in-class potential for its migraine drug candidate but offered few details. Now that Slate ...

The bottleneck in AI-enabled real-world data analysis is not computation, model architecture, or training data volume. It is ...

The public markets welcomed another biotech company this past week with the $81 million stock market debut of Vogenx, a metabolic medicines developer whose in-licensed lead drug candidate is in ...

Women’s health startups should plan for reimbursement early, as limited research and evidence can make securing coverage ...

PatientRightsAdvocate.org sued the American Medical Association this week, arguing the trade group has no valid copyright ...

When payors consider only the cost of the medication and not the cost and risk to the patient, doctor, and healthcare system, ...

Tolerance for this abrasion is gone. It wastes time, drains staff capacity, drives up costs, and affects ...

The FDA approved Moderna’s flu vaccine mFLUSIVA, a regulatory decision that comes six months after the agency refused to ...

UnityPoint Health's chief medical officer, Gregory Johnson, shared several ways the system is using AI to lift administrative ...

NOCD, a virtual provider for OCD, announced plans to expand its virtual intensive outpatient program for people with severe ...

M&A activity is going beyond big pharma acquisitions with Supernus Pharmaceuticals and Indivior Pharmaceuticals reaching a ...